BEYONDSPRING INC.

BYSI
Real-time Estimate Quote. Real-time Estimate  - 10/28 09:37:25 am
14.945USD -0.83%
Prev.15.0700
Open14.8500
High15.1500
Low14.5900
Volume48 666
Latest news
10/14
10/12
09/29
09/24
Chart BEYONDSPRING INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance15,618,218,5
Spread/Res.-3,5%-17%-18%
Spread/Supp.20%51%45%
Support12,69,9910,4
Financials
Sales 2020 - - -
Net income 2020 -60,7 M - -
Net Debt 2020 - - -
P/E ratio 2020 -7,25x
Yield 2020 -
Capitalization 454 M 454 M -
Capi. / Sales 2020 -
Capi. / Sales 2021 31,4x
Nbr of Employees 61
Free-Float 12,0%
Company
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. The Company’s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-05 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 3
Average target price 41,50 $
Last Close Price 15,07 $
Spread / Highest target 205%
Spread / Average Target 175%
Spread / Lowest Target 146%